GE11, a 12-amino-acid peptide, binds to the epidermal growth factor receptor (EGFR), which is overexpressed in 40–70% of breast cancers, particularly TNBC and HER2-positive subtypes [17]. The gene discussed is EGFR; the disease is breast cancer.